News Circio Holding ASA

Equities

TRVX

NO0013033795

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-04-24 am EDT			5-day change	1st Jan Change
2.84 ^NOK	+5.97%		-41.44%	-60.56%

Apr. 17	Circio Establishes In Vivo Proof-of-Concept for Circular RNA Platform	MT
Apr. 17	Circio to Raise Up to NOK60 Million via Rights Issue	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Circio Establishes In Vivo Proof-of-Concept for Circular RNA Platform	Apr. 17	MT
Circio to Raise Up to NOK60 Million via Rights Issue	Apr. 17	MT
Circio Terminates Cancer Vaccine License Deal in China	Apr. 17	MT
Circio : Company update 17 April 2024	Apr. 17	PU
Circio announces in vivo proof-of-concept for its circVec circular RNA platform technology and reinforced gene therapy focus	Apr. 17	AQ
Circio Announces in Vivo Proof-Of-Concept for Its circVec circular RNA Platform Technology and Reinforced Gene Therapy Focus	Apr. 17	CI
Transcript : Circio Holding ASA - Special Call	Apr. 17
Circio announces intention to raise around NOK 50-60 million in Q2 2024 to extend cash runway to Q2 2025	Apr. 17	AQ
Circio terminates TG01 cancer vaccine license option agreement with IOVaxis in China for non-payment	Apr. 17	AQ
Circio Holding ASA Terminates TG01 Cancer Vaccine License Option Agreement with IOVaxis therapeutics in China for Non-Payment	Apr. 17	CI
Circio Holding ASA: Requested Conversion of Convertible Bonds	Mar. 21	PU
Circio Partner Exercises Option to License Cancer Vaccine in China	Mar. 19	MT
Circio announces that partner IOVaxis Therapeutics has exercised the option for an exclusive license to mutant RAS cancer vaccine TG01 in China	Mar. 19	AQ
Circio Holding ASA Announces Partner IOVaxis Therapeutics Exercises the Option for an Exclusive License to Mutant RAS Cancer Vaccine TG01 in China	Mar. 19	CI
Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds	Mar. 13	AQ
Circio Holding ASA: Approval and publication of prospectus	Mar. 08	AQ
Circio : The TG01 IND application by Circio’s partner IOVaxis Therapeutics has been approved by the Chinese regulatory authorities	Mar. 04	PU
The TG01 IND application by Circio's partner IOVaxis Therapeutics has been approved by the Chinese regulatory authorities	Mar. 04	AQ
Circio Holding ASA: Requested Conversion of Convertible Bonds	Mar. 04	AQ
Circio to participate in the Annual European Life Sciences CEO Forum in Zürich	Feb. 27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Circio Holding ASA

Equities

TRVX

NO0013033795

Summary

Filters